Clinical Trials
24 trialsNCT06502483 2026-04-21
PRISM
Dana-Farber Cancer Institute
Phase NA Completed
NCT02867033 2026-03-30
ALTITUDES
Centre Oscar Lambret
Phase NA Active not recruiting
NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
NCT05111964 2026-02-04
SarcAblate
Oxford University Hospitals NHS Trust
Phase NA Recruiting
NCT02476305 2026-01-20
CRYODESMO01
University Hospital, Strasbourg, France
Phase NA Completed
NCT06081400 2025-11-19
CRYODESMO-02
University Hospital, Strasbourg, France
Phase NA Recruiting
NCT05949099 2025-09-08
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Stanford University
Phase 2 Recruiting
NCT05091255 2025-08-01
Cryotherapy in the Treatment of Desmoid Tumors
Istituto Ortopedico Rizzoli
Phase NA Recruiting
NCT02228889 2025-06-06
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Phase NA Completed
NCT03190174 2025-02-17
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
Phase 1/2 Completed
NCT02076906 2025-01-01
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Children's National Research Institute
Phase 1 Completed
NCT03802084 2024-05-13
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
Yonsei University
Phase 1/2 Completed
NCT06355921 2024-04-10
RFAdesmoid
Blokhin's Russian Cancer Research Center
Phase NA Not yet recruiting
NCT01265030 2023-06-26
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
MaineHealth
Phase 1/2 Completed
NCT05561036 2022-09-30
A Randomized, Double-blind,Phase â…¢ Study of Liposome Doxorubicin in Desmoid Tumor
Sun Yat-sen University
Phase 3 Unknown
NCT03275818 2022-06-07
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Completed
NCT03966742 2022-03-25
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Rabin Medical Center
Phase 2 Completed
NCT02374931 2019-10-03
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02557854 2019-03-19
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
University of Texas Southwestern Medical Center
Phase 1 Withdrawn
NCT01137916 2017-05-03
Study to Evaluate Imatinib in Desmoid Tumors
Heidelberg University
Phase 2 Completed
NCT00978146 2017-04-20
Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
Children's Hospital of Philadelphia
Phase 2 Withdrawn
NCT00287846 2016-08-30
Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
UNICANCER
Phase 1/2 Completed
NCT00474994 2016-01-20
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02353429 2015-02-02
Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown